Skip to main content

Table 3 Clinical information of patients providing urinary samples included for 2-DE analysis

From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

No. Age Sex Grade Two-tie grading system No. Age Sex Condition
1 57 F G2 I 41 56 M chronic inflammation of bladder
2 55 M G2 I 42 57 F chronic inflammation of bladder
3 65 M G1 I 43 66 M chronic inflammation of bladder
4 64 M G2 I 44 65 F bladder atypia hyperplasy
5 69 F G2 I 45 70 M bladder atypia hyperplasy
6 66 M G2 I 46 61 M bladder atypia hyperplasy
7 67 F G2 I 47 67 M bladder atypia hyperplasy
8 75 F G2 I 48 65 M inverted papilloma of bladder
9 51 M G1 I 49 50 F normal
10 69 F G1 I 50 53 F normal
11 60 M G1 I 51 56 F normal
12 62 M G1 I 52 58 F normal
13 60 M G2 I 53 70 M normal
14 61 M G2 I 54 72 M normal
15 69 M G2 I 55 61 M normal
16 67 F G1- G2 I 56 67 M normal
17 61 M G2 I 57 59 M normal
18 79 M G2 I 58 73 M normal
19 61 M G1- G2 I 59 75 M normal
20 59 F G2 I 60 64 M normal
21 54 M G2 I 61 58 M normal
22 48 M G2 I 62 52 M normal
23 56 M G1- G2 I 63 72 M normal
24 57 F G2 I 64 51 M normal
25 71 F G2-G3 II 65 50 M normal
26 80 F G2-G3 II 66 57 F normal
27 76 M G3 II 67 63 F normal
28 53 M G3 II 68 65 F normal
29 52 M G3 II 69 54 F normal
30 59 M G3 II 70 58 F normal
31 69 M G3 II 71 77 F normal
32 60 M G3 II 72 66 M normal
33 58 M G3 II     
34 39 M G3 II     
35 80 M G3 II     
36 55 M G3 II     
37 68 M G3 II     
38 72 M G3 II     
39 77 M G3 II     
40 59 M G3 II     
  1. I: Low Malignant BTCC; II: Aggressive BTCC